PR

Pavan Rathi

Active Director Additional Director DIN 07743436
DIN 07743436 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Apr 2017
Shareholding value •••• Premium profile

About Pavan Rathi

Data last updated:

Pavan Rathi is an Additional Director at Tirupatimsshree Pharmaceuticals Private Limited (since 2025), Director at Tirupati Eye Centre And Research Institute Private Limited (since 2024) and Director at Eyesphere Medicare Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Tourism And Accommodation. The 2 current companies with reported revenue have a combined latest revenue of ₹2.30 Cr; the largest is Tirupatimsshree Pharmaceuticals Private Limited at ₹2.13 Cr (FY 2025). Earlier, Pavan Rathi was a Director at Artfeat Designs Private Limited (2017–2021) and Designated Partner at Wellnovo Polyclinic Llp (2023–2024).

DIN 07743436
Primary Designation Additional Director
Industry Pharma
First Appointment 03 Apr 2017
Oldest Company Age 14 yrs
Largest company Tirupatimsshree Pharmaceuticals Private Limited · ₹2.13 Cr (FY 2025)
Combined revenue ₹2.30 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director09 Jun 20252022₹2.13 Cr (FY 2025)Active
Director04 Jan 20242012₹17.1 Lakh (FY 2025)Active
Eyesphere Medicare Private Limited U86900UP2024PTC203153
Director21 May 20242024Active
Vees Cafe Private Limited U55101DL2021PTC386388
Director10 Sep 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Artfeat Designs Private Limited U36999DL2017PTC315480
Director03 Apr 20172017₹52.2 Lakh (FY 2018)Strike Off
Designated Partner29 Jun 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vees Cafe Private Limited
Tirupati Eye Centre And Research Institute Private Limited
Tirupatimsshree Pharmaceuticals Private Limited
Eyesphere Medicare Private Limited
Premium access

Shareholding and investment profile for Pavan Rathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavan Rathi

Pavan Rathi currently holds 4 directorships: Tirupatimsshree Pharmaceuticals Private Limited (Additional Director, since 09 Jun 2025, revenue ₹2.13 Cr (FY 2025)); Tirupati Eye Centre And Research Institute Private Limited (Director, since 04 Jan 2024, revenue ₹17.1 Lakh (FY 2025)); Eyesphere Medicare Private Limited (Director, since 21 May 2024); Vees Cafe Private Limited (Director, since 10 Sep 2021).

Pavan Rathi was first appointed on 03 Apr 2017 as Director at Artfeat Designs Private Limited. The most recent appointment on record is 09 Jun 2025 at Tirupatimsshree Pharmaceuticals Private Limited.

The 2 current companies of Pavan Rathi that report revenue have a combined latest revenue of ₹2.30 Cr: Tirupatimsshree Pharmaceuticals Private Limited ₹2.13 Cr (FY 2025); Tirupati Eye Centre And Research Institute Private Limited ₹17.1 Lakh (FY 2025).

Pavan Rathi held 2 earlier board appointments: Artfeat Designs Private Limited (Director, 03 Apr 2017 to 01 Sep 2021); Wellnovo Polyclinic Llp (Designated Partner, 29 Jun 2023 to 27 Mar 2024).

The current boards of Pavan Rathi's companies include Mohita Sharma (Tirupatimsshree Pharmaceuticals Private Limited), Lovish Arora (Vees Cafe Private Limited), Manish Bhardwaj (Vees Cafe Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available